Implementing a Leadership Change
The late Don Ruiz left Gene One to his five grown children: Rich, Cathy, Kathryn, Sue, and Syam with instructions they will choose one leader and that leader must implement a successful initial public offering (IPO). Syam has been out of town so the remaining four siblings made the decision without him.
This paper will discuss the four members of the Gene One leadership team in which the siblings analyzed along with the findings and will announce who was chosen for the leadership position and why.
A change strategy that will effectively pair the selected leadership structure and styles with the vision of Gene One will be ...view middle of the document...
Dons untimely death has removed him from being chosen as the leader
Teri Roberson, Chief Technology Officer: Teri realizes there are tremendous opportunities in Gen One’s area of expertise that has not been noticed. Teri is committed to develop breakthrough technologies as well as the innovative products to bring to the market. Teri has 15 years of experience in research and nearly a dozen patents. She recently received Chief Technology Officer of the Year award (Learning Team C, 2010). Teri’s area of expertise is developing breakthrough technologies, removing her from this position to move her into the leadership position would be devastation to Gene One.
Michelle Houghton, Chief Financial Officer: Michelle has an excellent history of finding funding from both government and private investors. She is capable at building networks, teams and is a highly skilled Chief Financial Officer. She has proven herself as a negotiator and leader with a credible reputation with the Food and Drug Administration (FDA) leadership and the executive board. Michelle is passionate about Gene One and has vested her time, money and energy into the company. Michelle is a founding member of Gene One and can easily be the change agent and leader. She is the one that identified the need for an additional board member with a different financial background. When a new member is added to the team, Michelle will have additional resources to expand and work with the entire executive board to lead him or her into the IPO (Learning Team C, 2010).
The two running tenders for the leadership position are Charles and Michelle. The four siblings were spit on which one to choose but ultimately went with Michelle. Kathryn and Rich were leaning toward Charles based on the fact he can focus on the big picture and he is a smart risk taker. Charles is a leader in his field and knows how to make things happen. Charles strong morals go a long way with the two siblings who chose him. However, his lack of experience and investment in the company makes him a runner up for the leadership position.
Cathy and Sue chose Michelle as the leader because of her experience with the government and FDA. Michelle’s ability to net work and as a proven negotiation along with her credible reputation makes her a top pick. Michelle’s passion for Gene One and her vested time, money, and energy invites a leadership style. However, Kathryn and Rich are concerned about the fact that Michelle tends to put the horse before the cart and seems to stir things up.
The IPO is a complicated and time-consuming process that involves a high degree of risk and requires an extraordinary level of management commitment. On the surface, the transformation from private to public company appears fairly straightforward. In reality, the process involves more than just a sale of securities, and the outcome of many of the other factors related to going...